Binge Eating Disorder
📧 Sign up to get email alerts when something new happens for Binge Eating Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Atomoxetine in the Treatment of Binge Eating Disorder [Phase 4]
A Phase 4 clinical trial evaluating atomoxetine for the treatment of binge eating disorder has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity [Phase 3]
Phase 3 trial of lamotrigine for binge eating disorder associated with obesity has completed. The update does not report trial results.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity [Phase 2, Phase 3]
This entry notes the completion of Phase 2/Phase 3 trials evaluating the effectiveness and safety of topiramate for moderate to severe binge…
-
FDA approval · 2011-03-16FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder. [Phase 3]
Phase 3 trial evaluating the efficacy and tolerability of topiramate in obese patients with binge eating disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-11-10FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America.
-
CLINICAL_TRIALS trial_result · 2010-09-28Clinical Trial Update: The Psychological Treatment of Overweight Binge Eaters Minority Supplement [Phase 1, Phase 2]
Clinical trial update documenting completion of Phase 1 and Phase 2 for a minority-supplement study on psychological treatment for overweigh…
-
CLINICAL_TRIALS trial_result · 2010-09-23Clinical Trial Update: Psychological Treatment of Overweight Binge Eaters [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial from Washington University School of Medicine evaluating psychological treatment approaches, incl…
-
FDA approval · 2010-04-05FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental NDA for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, detailing a label/indication …
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Internet Weight Control for Bingeing Adolescents [Phase 1]
Phase 1 results update from NIDDK on an internet-based weight control program for adolescents with obesity and binge eating disorders. The t…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Treatment of Binge Eating Disorder [NA]
A clinical trial studying treatment options for Binge Eating Disorder has completed. This entry does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Treatment of Binge Eating Disorder [NA]
This document reports a completed clinical trial update for the treatment of binge eating disorder, with bulimia nervosa and obesity listed …
-
FDA approval · 2009-05-22FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc., authorizing cha…
-
CLINICAL_TRIALS trial_result · 2009-04-07Clinical Trial Update: Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients [Phase 3]
A Phase 3 trial assessing the efficacy and safety of rimonabant for weight loss and reducing binge episodes in obese patients has completed.…
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Topiramate for Binge Eating Disorder Among Adolescents [NA]
A completed clinical trial investigated topiramate for binge eating disorder in adolescents (including bulimia nervosa) with the study statu…
-
CLINICAL_TRIALS trial_result · 2007-10-02Clinical Trial Update: Meditation-Based Treatment for Binge Eating Disorder [Phase 2, Phase 3]
Completed Phase 2/Phase 3 clinical trial evaluating a meditation-based treatment for Binge Eating Disorder and obesity. The trial was sponso…
-
CLINICAL_TRIALS trial_result · 2007-08-31Clinical Trial Update: A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder [Phase 3]
A Phase 3 clinical trial evaluating Meridia (sibutramine hydrochloride) for binge-eating disorder has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-14Clinical Trial Update: An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder [Phase 4]
The document reports the completion of an open-label Phase 4 trial evaluating memantine for binge eating disorder.